Our Oncology Clinical Strategy is designed to transform survival

Home / Our therapy areas / Oncology / Clinical Strategy

At AstraZeneca, we think differently about the underlying genetic causes of cancer. Our clinical strategy aims to transform survival by seeking to combat metastatic and resistant disease and providing options to treat early. We are defining new biomarkers and therapeutic targets that cut across multiple tumour types. We are transforming the way people with cancer are diagnosed and treated by looking in new places, beyond traditional classifications and focusing on the properties of a tumour, not just its type.

Introduction to our clinical strategy

Our clinical stratgy is designed to transform survival. We aim to combat cancer at all stages, but we know that the earlier we can detect and address cancer, the closer we may be to better outcomes.

Trending stories

Latest Oncology News

Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative breast cancer
  • Corporate Press Release
Acquisition of Gracell completed
  • Corporate Press Release
Tagrisso with the addition of chemotherapy approved in the US for patients with EGFR-mutated advanced lung cancer
  • Corporate Press Release
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
  • Corporate Press Release
Tagrisso demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial
  • Corporate Press Release
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
  • Corporate Press Release
View all news and press releases

Explore our Oncology pillars

Medicines: Portfolio and Pipeline

With our portfolio, our pipeline and our people, we aim to revolutionise cancer care.

Patient Experience

We are catalysing changes in the practice of medicine to transform the patient experience.

Our People & Culture

Our people, passion and innovation drive us.